Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.135
+0.035 (3.18%)
Oct 8, 2026, 10:59 AM EDT - Market open
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $146.76 million as of October 8, 2026. It is the 23,094th most valuable company in the world and the 3,869th biggest in the United States. Its market cap has decreased by 43.08% in one year.
Market Cap
146.76M
Enterprise Value
143.21M
1-Year Change
-43.08%
Global Rank
Country Rank
#3,869 United States
Category
ChartMarket Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $146.76M, an increase of 0.55%. That is a compound annual growth rate of 0.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 146.76M | -17.10% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 152.63M |
| Acumen Pharmaceuticals | 152.59M |
| Voyager Therapeutics | 152.20M |
| Jyong Biotech | 152.18M |
| Codexis | 151.12M |
| Korro Bio | 149.61M |
| Armata Pharmaceuticals | 147.61M |
| Anavex Life Sciences | 146.92M |